Atrion Corporation (NASDAQ:ATRI) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported $4.29 EPS for the quarter, Bloomberg Earnings reports. Atrion Corporation had a net margin of 22.75% and a return on equity of 18.67%. The company had revenue of $37.90 million for the quarter.

Atrion Corporation (NASDAQ:ATRI) traded down $3.20 during trading hours on Thursday, reaching $645.05. 5,526 shares of the company’s stock traded hands, compared to its average volume of 4,158. Atrion Corporation has a one year low of $433.95 and a one year high of $694.00. The stock has a market capitalization of $1,200.00, a price-to-earnings ratio of 39.78 and a beta of 0.86.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Friday, December 1st will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, November 30th. Atrion Corporation’s payout ratio is 26.89%.

In other news, Chairman Emile A. Battat sold 1,408 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $652.91, for a total transaction of $919,297.28. Following the sale, the chairman now directly owns 148,881 shares of the company’s stock, valued at approximately $97,205,893.71. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 23.10% of the company’s stock.

Separately, BidaskClub lowered shares of Atrion Corporation from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 27th.

ILLEGAL ACTIVITY WARNING: “Atrion Corporation (ATRI) Issues Quarterly Earnings Results” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at

Atrion Corporation Company Profile

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

Earnings History for Atrion Corporation (NASDAQ:ATRI)

Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.